(Q35233563)

7 August 2017

title

An observational study of once-daily modified-release methylphenidate in ADHD: effectiveness on symptoms and impairment, and safety (English)

1 reference

7 August 2017

4

Aribert Rothenberger

0 references

author name string

Manfred Döpfner

series ordinal

1

1 reference

7 August 2017

Anja Görtz-Dorten

series ordinal

2

1 reference

7 August 2017

Dieter Breuer

series ordinal

3

1 reference

7 August 2017

publication date

1 October 2011

1 reference

European Child & Adolescent Psychiatry

7 August 2017

published in

1 reference

7 August 2017

volume

20 Suppl 2

1 reference

7 August 2017

page(s)

S243-55

1 reference

https://scigraph.springernature.com/pub.10.1007/s00787-011-0202-4

7 August 2017

exact match

0 references

cites work

An observational study of once-daily modified-release methylphenidate in ADHD: quality of life, satisfaction with treatment and adherence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3180616

Assessment of daily profiles of ADHD and ODD symptoms, and symptomatology related to ADHD medication, by parent and teacher ratings

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3180616

European guidelines on managing adverse effects of medication for ADHD.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3180616

A 6-month, open-label, extension study of the tolerability and effectiveness of the methylphenidate transdermal system in adolescents diagnosed with attention-deficit/hyperactivity disorder

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3180616

Drug and non-drug treatments of children with ADHD and tic disorders

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3180616

The worldwide prevalence of ADHD: a systematic review and metaregression analysis

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3180616

Efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3180616

Methylphenidate controlled-delivery capsules (EquasymXL, Metadate CD): a review of its use in the treatment of children and adolescents with attention-deficit hyperactivity disorder

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3180616

Comparison of the clinical efficacy of twice-daily Ritalin and once-daily Equasym XL with placebo in children with Attention Deficit/Hyperactivity Disorder

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3180616

First-onset tics in patients with attention-deficit-hyperactivity disorder: impact of stimulants

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3180616

Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3180616

The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3180616

Evidence for unexpected weaknesses in learning in children with attention-deficit/hyperactivity disorder without reading disabilities

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3180616

Emergence of tics in children with ADHD: impact of once-daily OROS methylphenidate therapy

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3180616

A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3180616

Management of ADHD in adults.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3180616

Does the treatment of attention-deficit/hyperactivity disorder with stimulants contribute to drug use/abuse? A 13-year prospective study

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3180616

A postmarketing clinical experience study of Metadate CD.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3180616

Methylphenidate bioavailability from two extended-release formulations

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3180616

Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3180616

Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3180616

The Strengths and Difficulties Questionnaire: a research note

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3180616

Stimulant medications precipitate Tourette's syndrome

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3180616

The assessment of Attention Deficit Hyperactivity Disorder (ADHD) by teacher ratings - validity and reliability of the FBB-HKS

13 July 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00787-011-0202-4

Preschool children with attention-deficit/hyperactivity disorder: impairments in behavioral, social, and school functioning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00787-011-0202-4

Psychometric properties of two ADHD questionnaires: comparing the Conners' scale and the FBB-HKS in the general population of German children and adolescents--results of the BELLA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00787-011-0202-4

A double-blind, placebo-controlled study of modified-release methylphenidate in children with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00787-011-0202-4

The Worldwide Prevalence of ADHD: A Systematic Review and Metaregression Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00787-011-0202-4

Symptom control in children and adolescents with attention-deficit/hyperactivity disorder on switching from immediate-release MPH to OROS MPH Results of a 3-week open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00787-011-0202-4

Psychometric properties of the parent strengths and difficulties questionnaire in the general population of German children and adolescents: results of the BELLA study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00787-011-0202-4

Efficacy of methylphenidate, psychosocial treatments and their combination in school-aged children with ADHD: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00787-011-0202-4

Attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00787-011-0202-4

National Institutes of Health Consensus Development Conference Statement: diagnosis and treatment of attention-deficit/hyperactivity disorder (ADHD)

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21901417

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

[Normal values and evaluation of the German parents' version of Strengths and DIfficulties Questionnaire (SDQ): Results of a representative field study]

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21901417

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

[Switching from a short-acting to a long-acting methylphenidate preparation: a multicentre, open study in children with ADHD]

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21901417

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00787-011-0202-4

1 reference

7 August 2017

1 reference

7 August 2017

1 reference